1995 – Post-doctorate in Molecular Virology, Department of Cancer Biology, Harvard School of Public Health.
1989 – Specialty in Infectology, INNSZ.
1987 – Specialty in Internal Medicine, INNSZ.
1982 – Surgeon, La Salle University.
Academic appointments:
Head of the Molecular Virology laboratory and head researcher of the Department of Infectology of the National Institute of Medical Sciences and Nutrition “Salvador Zubirán.”
National System of Researchers, Level I.
Professor of Infectology at the Faculty of Medicine of La Salle University since 1997.
Representative of Latin America before the International AIDS Society (International AIDS Society-IAS).
Research interests:
HIV/AIDS.
SELECTED PUBLICATIONS
Hospital-based hepatitis C screening in a tertiary care centre in Mexico: targeted at health care-associated transmission. Lopez Luis BA, Moyado-Ocampo KL, Soto-Ramírez LE. Infect Dis (Lond). 2019 Oct 23:1-3.
Immediate treatment of acute HIV in a tertiary healthcare center: bridging gaps in communication using smartphones. Perez-Patrigeon S, Camiro-Zúñiga A, Jaramillo-Jante MR, Belaunzarán-Zamudio PF, Crabtree-Ramírez B, Soto-Ramírez LE, Calva JJ, Hernández-León C, Mosqueda-Gómez JL, Navarro-Alvarez S, Sierra-Madero JG. HIV Med. 2019 May;20(5):308-316.
Histoplasma panniculitis in a patient with systemic lupus erythematosus. Flores-Bozo LR, Ortiz-Brizuela E, Soto-Ramírez LE. An Bras Dermatol. 2019 Jan-Feb;94(1):96-98.
An immunocompromised patient & multiorgan cystic echinococcosis. Lopez Luis BA, Valdivia-Cayoja AR, Belaunzaran-Zamudio PF, Soto-Ramírez LE. QJM. 2019 Mar 1;112(3):215-217.
World hepatitis day. Fighting hepatitis C in Latin America and the Caribbean; an urgent call. Soto-Ramirez LE. J Int AIDS Soc. 2017 Jul 28;20(1):22183.
The successful application of a national peer advisory committee for physicians who provide salvage regimens to heavily antiretroviral-experienced patients in mexican human immunodeficiency virus clinics. Calva JJ, Sierra-Madero J, Soto-Ramírez LE, Aguilar-Salinas P. Open Forum Infect Dis. 2014 Sep 10;1(2):ofu081.
Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods. Bertagnolio S, Rodriguez-Diaz RA, Fuentes-Romero LL, Bennett DE, Viveros-Rogel M, Hart S, Pilon R, Sandstrom P, Soto-Ramirez LE. Clin Infect Dis. 2012 May;54 Suppl 4:S328-33.
Effects of progesterone on the content of CCR5 and CXCR4 coreceptors in PBMCs of seropositive and exposed but uninfected Mexican women to HIV-1. Cabrera-Muñoz E, Fuentes-Romero LL, Zamora-Chávez J, Camacho-Arroyo I, Soto-Ramírez LE. J Steroid Biochem Mol Biol. 2012 Oct;132(1-2):66-72.
Prospective, randomized, open label trial of Efavirenz vs Lopinavir/Ritonavir in HIV+ treatment-naive subjects with CD4+<200 cell/mm3 in Mexico. Sierra-Madero J, Villasis-Keever A, Méndez P, Mosqueda-Gómez JL, Torres-Escobar I, Gutiérrez-Escolano F, Juárez-Kasusky I, Magana-Aquino M, Ramos-Santos C, Pérez-Saleme L, Rangel-Frausto S, Antuna-Puente B, Soto-Ramírez LE, Lima V, Belaunzarán-Zamudio F, Crabtree-Ramírez B, Montaner J. J Acquir Immune Defic Syndr. 2010 Apr;53(5):582-8.
HIV Drug Resistance-Associated Mutations in Antiretroviral Naïve HIV-1-Infected Latin American Children. Soto-Ramirez LE, Rodriguez-Diaz R, Harris DR, Hazra R. Adv Virol. 2010;2010:407476.